ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,255.20
      1.29%
      Dow Jones
      40,415.44
      0.32%
      Brent Oil
      81.525
      0.01%
      Bitcoin
      67,589.19
      -0.02%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Ipsen SA (IPN) Quote

      Ipsen SA

      Ipsen SA (IPN)

      EU
      110.50
      1.20
      (1.10%)
      Closed July 22 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      110.50
      Bid
      110.20
      Ask
      110.80
      Volume
      66,980
      109.90 Day's Range 111.20
      99.70 52 Week Range 130.70
      Market Cap
      8.966B
      Previous Close
      109.30
      Open
      110.00
      Last Trade
      19
      @
      110.5
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      76,223
      Shares Outstanding
      82,029,421
      Dividend Yield
      1.09%
      PE Ratio
      14.07
      Earnings Per Share (EPS)
      7.86
      Revenue
      3.37B
      Net Profit
      644.4M

      About Ipsen SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.ipsen.com
      Headquarters
      Boulogne-billancourt, Hauts-de-seine, Fra
      Founded
      1970
      Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 109.30 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 130.70 €.

      Ipsen currently has 82,029,421 shares outstanding. The market capitalization of Ipsen is 8.97 € billion. Ipsen has a price to earnings ratio (PE ratio) of 14.07.

      IPN Latest News

      More News

      IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024

      IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024 Aggregated presentation by day and by market Purchases of own shares from July 8th to 12th  2024       Name of the IssuerIdentity code of...

      July 16 2024
      UK Regulatory

      IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2024

      IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2024 Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres...

      July 16 2024
      UK Regulatory

      Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential

      Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potentialFS001 targets a novel...

      July 11 2024
      GlobeNewswire Inc.

      Ipsen et Foreseen Biotechnology annoncent la signature d’un accord exclusif de licence mondiale pour un conjugué anticorps-médicament doté d'un potentiel de première classe

      Ipsen et Foreseen Biotechnology annoncent la signature d’un accord exclusif de licence mondiale pour un conjugué anticorps-médicament doté d'un potentiel de première classe Ipsen a obtenu les...

      July 11 2024
      UK Regulatory

      Ipsen - June 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

      Ipsen - June 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and...

      July 09 2024
      UK Regulatory

      IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024

      IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024 Aggregated presentation by day and by market Purchases of own shares from July 1st to 5th 2024       Name of the IssuerIdentity code of...

      July 09 2024
      UK Regulatory

      Ipsen - Juin 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

      Ipsen - Juin 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de voteet...

      July 09 2024
      UK Regulatory

      Half-year statement of IPSEN liquidity agreement - 2024 06 30

      Half-year statement of IPSEN liquidity agreement - 2024 06 30 Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF PARIS, FRANCE, July 8, 2024 - Under the liquidity...

      July 08 2024
      GlobeNewswire Inc.

      IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2024

      IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2024 Présentation agrégée par jour et par marché Déclaration des transactions sur actions...

      July 02 2024
      GlobeNewswire Inc.

      Ipsen étend sa collaboration et son accord de licence pour le développement de Cabometyx® dans le traitement des tumeurs neuroendocrines avancées sur la base des résultats positifs de l’essai de Phase III CABINET

      Ipsen étend sa collaboration et son accord de licence pour le développement de Cabometyx® dans le traitement des tumeurs neuroendocrines avancées sur la base des résultats positifs de l’essai...

      July 02 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.7-0.629496402878111.2112.2109.260154110.56032011DE
      4-3.3-2.89982425308113.8118.4107.274710112.64432268DE
      12-2.6-2.29885057471113.1126.7107.276223117.12235152DE
      265.24.93827160494105.3126.799.775734111.4313638DE
      52-0.4-0.360685302074110.9130.799.774686112.25375942DE
      1562427.745664739986.5130.77783366101.94672208DE
      260-2.7-2.3851590106113.2130.734.210757688.35302898DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MIRAMIRA Pharmaceuticals Inc
      $ 5.01
      (627.35%)
      		157.94M
      CMAXCareMax Inc
      $ 5.19
      (228.48%)
      		102.61M
      NUKKNukkleus Inc
      $ 0.499
      (55.94%)
      		26.19M
      SNOASonoma Pharmaceuticals Inc
      $ 0.423
      (37.34%)
      		4.87M
      ONDSOndas Holdings Inc
      $ 1.1297
      (34.06%)
      		2.19M
      LGCBLinkage Global Inc
      $ 3.6601
      (-29.82%)
      		168k
      CGBSCrown LNG Holdings Ltd
      $ 0.9997
      (-29.10%)
      		3.38M
      SPECSpectaire Holdings Inc
      $ 0.3962
      (-24.53%)
      		1.87M
      GSUNGolden Sun Health Technology Group Ltd
      $ 5.13
      (-23.66%)
      		158.58k
      PSNLPersonalis Inc
      $ 2.9808
      (-22.58%)
      		3.1M
      NVDANVIDIA Corporation
      $ 123.54
      (4.76%)
      		238.8M
      SQQQProShares UltraPro Short QQQ
      $ 8.09
      (-4.37%)
      		183.24M
      MIRAMIRA Pharmaceuticals Inc
      $ 5.01
      (627.35%)
      		157.94M
      SERVServe Robotics Inc
      $ 8.73
      (15.63%)
      		151.44M
      NCPLNetcapital Inc
      $ 0.1118
      (7.50%)
      		124.21M

      Discussion

      View Full Feed
      patrik patrik 40 seconds ago
      W2R,
      But there are some here expecting any day kaboom! I’m looking
      at end of year or possibility early 2025
      Patrik
      KBLB
      Stinger2014 Stinger2014 2 minutes ago
      The good news, the MC can’t get much lower. I still believe the RS is already baked in.
      CGAC
      DesertDrifter DesertDrifter 3 minutes ago
      Yep. I was just thinking out loud. Still not a lot of official stuff coming out about the Ear of Trump episode. No legit medical release that mentions any stitches, grafts, etc. the photos of him golfing without bandage the day after with no visible wounds seems still curious.
      fuagf fuagf 3 minutes ago
      Yep. It's a must do now after you've thrown that gauntlet down. https://www.democraticunderground.com/emoticons/toast.gif
      LCJR LCJR 3 minutes ago
      Volume seems correct. Not sure about the individual trades though.

      LCJR
      AAGC
      somberfox somberfox 3 minutes ago
      All of that experience, and here we are at near trip 0s with millions in dilution, a deal with your biggest partner gone in the wind and a month behind on an audit of nothing.

      Hey, we're getting a watch though.
      RONN
      SSKILLZ1 SSKILLZ1 4 minutes ago
      SSKMP Managed Index (As Of 7/22/24)

      Daily Performance
      -0.08%

      YTD Performance
      +5.20%

      Overall Performance
      +494.90% (Including Options Trading +358.88%)
      ExtremelyBullishZig ExtremelyBullishZig 4 minutes ago
      Cool! So he can bring the drug to market then? Or is he just better at making the science work...I am trying to figure this one out. Steady told us that no one's opinion matters...
      AVXL
      ddls ddls 5 minutes ago
      Yes, let's get this-junk going, for the note-holders.

      https://www.otcmarkets.com/otcapi/company/financial-report/397773/content
      BIEL
      janice shell janice shell 5 minutes ago
      I've never even thought of making my own ketchup. And I've been eating Heinz all my life. I'm still alive. I don't use all that much of it, though. I use much more mayo.
      Ashley250nelson Ashley250nelson 5 minutes ago
      Trials starting next week!lfgo Jim saved us
      GSTC
      GMH* GMH* 6 minutes ago
      The company themselves said that the dropout rate will decline over time, so I am going from that, but they also said it was in-line with trials. Also, note that the 5% drop was, I assume, from patient health decline. There was also a statement in the same article that the manufacturing success ra
      IOVA
      bigstocksnbonds bigstocksnbonds 6 minutes ago
      YES SIR!!!!!
      MasterBlastr MasterBlastr 6 minutes ago
      Have to take advantage of the rules of the game, to make it fair.
      bigstocksnbonds bigstocksnbonds 6 minutes ago
      Awesome yes!!!!!
      Real McCoy Real McCoy 7 minutes ago
      If you are going to start the cycle by saying that some folks here are cruelly committed to not allowing complete lies and fantasies to sit unrefuted, I will gladly complete the cycle by noting you are also guilty of an equal committment to fight for the right to say you believe said lies and fantas
      Scott 75 Scott 75 7 minutes ago
      Hopefully not on a cold slab somewhere.
      UATG
      janice shell janice shell 8 minutes ago
      Bobo is just so breathtakingly stupid.
      BADALI BADALI 8 minutes ago
      I am watching this week and will add if goes Lower.
      HIRU
      _-Abe-_ _-Abe-_ 8 minutes ago
      Just remember. This company has a pile of back orders to fill and are now able to begin that process. I’m looking forward to Q4 numbers.
      EOSE
      Genz2 Genz2 9 minutes ago
      https://www.theregister.com/AMP/2024/07/22/windows_crowdstrike_kernel_eu/

      Why is Microsoft blaming the EU when it is apparent that they didn’t allow Wave on Windows 10 and 11? I think they allowed Crowdstrike on their platform because they knew that Clownstrike was inferior to Window
      moosedogger moosedogger 9 minutes ago
      "I won't sell for less than "60.00"

      Prove that you really missed me! I think you are not only FOS but also suffer from excrement of the 11th magnitude clogging what used to be your brain.

      You might be the saddest and mentally sickest creature on the iHub boards.
      AUPH
      irishintelligence irishintelligence 9 minutes ago
      Who knows - it obviously does not matter. Nothing is stopping him from continuing to develop property.


      http://cdn.ceo.ca.s3-us-west-2.amazonaws.com/1dr223l-Anatomy%20of%20a%20Basher%20-%20Do%20and%20Don%27t.pdf

      “Use 10% fact and 90% suggestion”

      Fa
      SPZI

      Your Recent History

      EU
      IPN
      Ipsen
      BIT
      UV8BT1
      UniCredit Bank
      NASDAQ
      LGCY
      Delayed Upgrade Clock